Page last updated: 2024-10-31

miconazole and Atypical Mycobacterial Infection, Disseminated

miconazole has been researched along with Atypical Mycobacterial Infection, Disseminated in 1 studies

Miconazole: An imidazole antifungal agent that is used topically and by intravenous infusion.
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole : A member of the class of imidazoles that is 1-(2,4-dichlorophenyl)-2-(imidazol-1-yl)ethanol in which the hydroxyl hydrogen is replaced by a 2,4-dichlorobenzyl group.
miconazole : A racemate composed of equimolar amounts of (R)- and (S)-miconazole. Used (as its nitrate salt) to treat skin infections such as athlete's foot, jock itch, ringworm and other fungal skin infections. It inhibits the synthesis of ergosterol, a critical component of fungal cell membranes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Anjos, LRBD1
Costa, VAF1
Neves, BJ1
Junqueira-Kipnis, AP1
Kipnis, A1

Other Studies

1 other study available for miconazole and Atypical Mycobacterial Infection, Disseminated

ArticleYear
Repurposing miconazole and tamoxifen for the treatment of Mycobacterium abscessus complex infections through in silico chemogenomics approach.
    World journal of microbiology & biotechnology, 2023, Aug-09, Volume: 39, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Drug Repositioning; Mice; Miconazole; Microbial Sensitivity Tests; M

2023